Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
03/2011
03/16/2011EP2294074A1 Phosphite stabilizer for lubricating base stocks and thermoplastic polymers
03/16/2011EP2294073A1 Process for the production of n-acyl-phosphatidyl-etanolamine
03/16/2011EP2293876A1 Ethylene-tetrafluoroethylene phosphate composition
03/16/2011EP2293874A2 Metal utilization in supported, metal-containing catalysts
03/16/2011EP2047534B1 White electroluminescent organic diodes based on molecules derived from phosphole.
03/16/2011EP2025661B1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof
03/16/2011EP1567468B1 A selective synthesis of organophosphites
03/16/2011CN1810815B Nitroimidazole derivative for treatment
03/16/2011CN101985455A Method for synthesizing flame retardant hexaphenoxy cyclotriphosphazene
03/16/2011CN101985454A Novel crystal form of tenofovir ester maleate, preparation method and pharmaceutical application thereof
03/16/2011CN101985453A 4-aminopyridine derivative and preparation method and application thereof
03/16/2011CN101985452A Regeneration technology of tributyl phosphate
03/16/2011CN101985413A Onium salt compound
03/16/2011CN101265272B Method of extracting phospholipid from crude glycerine
03/15/2011US7906688 Calixarene bisphosphite ligand for use in hydroformylation processes
03/15/2011US7906681 Tetramerization
03/15/2011US7906674 Oxidized phospholipids
03/15/2011US7906670 Biocompatibility, moisture retaining properties; chromatography packing; filter; glass devices
03/15/2011US7906669 Metallocene-based phosphorus chiral phosphines
03/15/2011US7906668 Imide complex, method for producing the same, metal-containing thin film and method for producing the same
03/15/2011US7906545 Prodrugs of CC-1065 analogs
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/15/2011CA2550660C Florfenicol prodrug having improved water solubility
03/15/2011CA2501565C Phosphitylation process
03/15/2011CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
03/15/2011CA2402038C Lpa receptor agonists and antagonists and methods of use
03/15/2011CA2360415C Benzimidazole vascular damaging agents
03/10/2011WO2011028594A2 Cancer starvation therapy
03/10/2011US20110060574 Computer-based modeling and designing of phosphofructokinase 1 (pfk) modulators
03/10/2011US20110060150 Method of detecting fluorescence
03/10/2011US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists
03/10/2011US20110059923 Novel phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component
03/10/2011US20110059922 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
03/10/2011US20110059921 Oligomer-Nitrogenous Base Conjugates
03/10/2011US20110059907 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care
03/10/2011US20110059893 Compounds for the treatment of proliferative disorders
03/10/2011US20110057184 Compound for organic electroluminescent device and organic electroluminescent device
03/10/2011US20110056841 System and method for direct conversion of solar energy to chemical energy
03/09/2011EP2293357A1 Compound for organic electroluminescent elements and organic electroluminescent element
03/09/2011EP2292628A2 Compounds for preparing immunological adjuvant
03/09/2011EP2292595A1 Potassium channel modulators
03/09/2011EP2291387A2 Hydroformylation catalysts
03/09/2011EP2291386A1 Crystalline form of tenofovir disoproxil and a process for its preparation
03/09/2011EP2291348A1 Water-soluble acetaminophen analogs
03/09/2011EP2291084A1 Carbonate prodrugs and methods of using the same
03/09/2011EP1585730B1 Carboxamide derivatives and their use as factor xa inhibitors
03/09/2011EP1578888B1 Production and use of in situ-modified nanoparticles
03/09/2011EP1578733B1 Process for the preparation of rosuvastatin
03/08/2011US7902741 Fluorescent complex and lighting system using the same
03/08/2011US7902403 Dithiophosphate composition and utility in rubber
03/08/2011US7902389 Catalyst complex with carbene ligand
03/08/2011US7902368 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines
03/08/2011US7902207 Process for production of amines
03/08/2011US7902202 Compounds and pharmaceutical compositions for the treatment of viral infections
03/08/2011US7902176 Etherified oxidized phospholipids for inducing tolerance to oxidized LDL via mucosal administration; 1-hexadecyl-2-(5'-oxo-pentanyl)-sn-glycero-3-phosphocholine (D-ALLE)
03/08/2011US7902175 Aminopropanol derivatives
03/08/2011US7902132 Additive system for lubricants
03/08/2011US7901812 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
03/08/2011CA2496883C Process for the enantioselective hydrogenation of amino alcohols
03/08/2011CA2446756C Thiazole compounds useful as inhibitors of protein kinase
03/03/2011WO2011026024A2 Imidazo [4,5-d] pyridazine compounds for treating viral infections
03/03/2011WO2011025541A1 Cannabinoid receptor modulators
03/03/2011WO2011024006A1 Compound
03/03/2011WO2011024004A1 Heterocyclic urea derivatives useful for treatment of bacterial infection
03/03/2011WO2011023624A1 Bisphosphonates as inhibitors of acid sphingomyelinase
03/03/2011WO2011023280A1 Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
03/03/2011WO2008125911A3 Hydrogen splitting composition
03/03/2011WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors
03/03/2011US20110054216 Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
03/03/2011US20110054212 Lithographic printing plate precursor and lithographic printing process
03/03/2011US20110054205 Sulfonated organophosphine compounds and use thereof in hydroformylation processes
03/03/2011US20110054204 Sulfonated organophosphine compounds and use thereof in hydroformylation processes
03/03/2011US20110054203 Sulfonated organophosphine compounds and use in hydroformylation processes
03/03/2011US20110054188 Near infrared fluorescent imaging agent
03/03/2011US20110054165 Xanthene dyes
03/03/2011US20110054087 Flame-Retardant cyanate esters
03/03/2011US20110054079 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
03/03/2011US20110054078 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
03/03/2011US20110054077 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
03/03/2011US20110054019 Cancer Starvation Therapy
03/03/2011US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases
03/03/2011US20110053895 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
03/03/2011US20110053893 Compounds and compositions as tlr activity modulators
03/03/2011US20110053892 Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections
03/03/2011US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity
03/03/2011US20110053162 Reactive cyanine compounds
03/03/2011US20110052534 Imidazopyridazine Compounds for Treating Viral Infections
03/03/2011US20110049442 Surface structures for enhancement of quantum yield in broad spectrum emission nanocrystals
03/03/2011US20110048923 Process for the Surface Modification of Particles
03/03/2011DE102009037691A1 Dielektrische Schutzschicht für eine selbstorganisierende Monolage (SAM) Dielectric protective layer for a self-assembled monolayer (SAM)
03/03/2011DE102009029050A1 Organophosphorverbindungen basierend auf Tetraphenol(TP)-substituierten Strukturen Organophosphorus compounds based on tetraphenol (TP) -substituted structures
03/03/2011CA2771933A1 Bisphosphonates as inhibitors of acid sphingomyelinase
03/03/2011CA2770866A1 Cannabinoid receptor modulators
03/02/2011EP2289901A1 Olefin oligomerization catalysts and methods of using same
03/02/2011EP2289900A1 Bisphosphonates as inhibitors of acid sphingomyelinase
03/02/2011EP2289899A1 New ionic liquids based on dithiophosphate anions and preparations thereof
03/02/2011EP2289892A1 Maleimide derivatives, pharmaceutical compositions amd methods for treatment of cancer
03/02/2011EP2289871A1 7-substituted tetracycline compounds
03/02/2011EP2288615A1 Selective caspase inhibitors and uses thereof
03/02/2011EP2207421B1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 554